Russell Investments Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Russell Investments Group’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.07M	Buy	350,429 +52,865	+18%	+$724K	0.01%	1388
2026 Q1	$3.7M	Sell	297,564 -91,793	-24%	-$1.23M	﹤0.01%	1525
2025 Q4	$4.93M	Sell	389,357 -156,673	-29%	-$1.79M	0.01%	1338
2025 Q3	$5.44M	Sell	546,030 -17,052	-3%	-$153K	0.01%	1260
2025 Q2	$4.56M	Buy	563,082 +79,278	+16%	+$598K	0.01%	1271
2025 Q1	$4.03M	Buy	483,804 +217,877	+82%	+$1.82M	0.01%	1281
2024 Q4	$2.1M	Buy	265,927 +99,807	+60%	+$837K	﹤0.01%	1644
2024 Q3	$1.38M	Sell	166,120 -15,055	-8%	-$118K	﹤0.01%	1881
2024 Q2	$1.15M	Buy	181,175 +5,490	+3%	+$34.9K	﹤0.01%	1910
2024 Q1	$1.06M	Sell	175,685 -470,242	-73%	-$2.65M	﹤0.01%	1951
2023 Q4	$3.92M	Sell	645,927 -107,457	-14%	-$479K	0.01%	1250
2023 Q3	$3.18M	Buy	753,384 +744,063	+7,983%	+$2.77M	0.01%	1306
2023 Q2	$28.9K	Sell	9,321 -103,155	-92%	-$220K	﹤0.01%	2787
2023 Q1	$156K	Sell	112,476 -363,555	-76%	-$724K	﹤0.01%	2517
2022 Q4	$947K	Sell	476,031 -41,177	-8%	-$92.3K	﹤0.01%	1998
2022 Q3	$1.04M	Buy	517,208 +24,908	+5%	+$69.8K	﹤0.01%	1914
2022 Q2	$1.56M	Sell	492,300 -25,945	-5%	-$94K	﹤0.01%	1719
2022 Q1	$2.16M	Buy	518,245 +38,555	+8%	+$171K	﹤0.01%	1604
2021 Q4	$2.3M	Sell	479,690 -142,421	-23%	-$710K	﹤0.01%	1722
2021 Q3	$3.32M	Buy	622,111 +342,623	+123%	+$1.72M	0.01%	1493
2021 Q2	$1.43M	Buy	279,488 +138,305	+98%	+$786K	﹤0.01%	2134
2021 Q1	$949K	Sell	141,183 -27,151	-16%	-$150K	﹤0.01%	2266
2020 Q4	$768K	Buy	168,334 +91,526	+119%	+$406K	﹤0.01%	2239
2020 Q3	$297K	Buy	+76,808	New	+$329K	﹤0.01%	2613
2020 Q2	–	Sell	-208,396	Closed	-$724K	–	3121
2020 Q1	$724K	Buy	+208,396	New	+$883K	﹤0.01%	2001
2019 Q2	–	Sell	-26,300	Closed	-$373K	–	2856
2019 Q1	$373K	Buy	26,300 +5,700	+28%	+$75.3K	﹤0.01%	2437
2018 Q4	$279K	Sell	20,600 -1,100	-5%	-$19.8K	﹤0.01%	2511
2018 Q3	$482K	Sell	21,700 -4,350	-17%	-$91.5K	﹤0.01%	2406
2018 Q2	$427K	Buy	+26,050	New	+$457K	﹤0.01%	2445

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Russell Investments Group's AMRX Position: Q2 2026 in Review

Russell Investments Group increased its Amneal Pharmaceuticals (AMRX) stake by 18% in Q2 2026, buying an estimated $724K and bringing the position to 350,429 shares worth $6.07M. The position accounts for 0.01% of the portfolio, ranked #1388.

Russell Investments Group first reported a position in AMRX in Q2 2018 and has held it in 29 quarters since. 129 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Russell Investments Group held 350,429 shares of Amneal Pharmaceuticals worth $6.07M as of Q2 2026.
Russell Investments Group bought 52,865 Amneal Pharmaceuticals shares in Q2 2026, an estimated $724K.
Amneal Pharmaceuticals made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1388 holding.
Russell Investments Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 29 quarters since.
129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.